SCHEMBL651311

SCHEMBL651311

O=C1N/C(=N/Cc2ccc(F)c(Cl)c2)S/C1=C\c1cnc(NC(=O)C2CC2)s1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.41
CDC25B P30305 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
PIM1 P11309 2/20 0.38
GSK3B P49841 3/20 0.37
HPGD P15428 2/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
LIMK1 P53667 1/20 0.36
LIMK2 P53671 1/20 0.36
ALOX12 P18054 1/20 0.36
MALT1 Q9UDY8 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL651620 0.90 PTPN1 (0.42) PTPN1CDC25BSMN1; SMN2PIM1GSK3B
SCHEMBL651619 0.90 PTPN1 (0.42) PTPN1CDC25BSMN1; SMN2PIM1GSK3B
SCHEMBL651064 0.89 PIM1 (0.47) PTPN1CDC25BPIM1GSK3BHPGD
SCHEMBL650973 0.85 LMNA (0.39) PTPN1CDC25BSMN1; SMN2PIM1GSK3B
SCHEMBL10176414 0.85 HPGD (0.53) PTPN1CDC25BGSK3BHPGDPOLB
SCHEMBL651957 0.84 LMNA (0.41) PTPN1CDC25BSMN1; SMN2GSK3BHPGD
SCHEMBL651355 0.84 PTPN1 (0.46) PTPN1CDC25BPIM1GSK3BHPGD
SCHEMBL10176413 0.83 PTPN1 (0.44) PTPN1CDC25BPIM1GSK3BHPGD
SCHEMBL648559 0.83 SMN1; SMN2 (0.42) PTPN1CDC25BSMN1; SMN2PIM1GSK3B
SCHEMBL649069 0.82 PTPN1 (0.42) PTPN1CDC25BPIM1GSK3BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 PTPN1 1863/4885CDC25B 59/4885SMN1; SMN2 4601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.